Top Markets
#1 TENDIES TENDIES +31.34%
#2 ICON ICON +26.61%
#3 Cash Cat Cash Cat +22.92%
#4 Threshold Network Threshold Network +20.14%
#5 OSK OSK +15.74%
#6 Magma Finance Magma Finance +12.58%
#7 Asteroid Shiba Asteroid Shiba +12.44%
#8 Ape and Pepe Ape and Pepe +11.65%
#9 Kite Kite +11.54%
#10 龙虾 (Lobster) 龙虾 (Lobster) +10.56%
Coin of the day
TENDIES TENDIES
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Oryzon Genomics S.A. Oryzon Genomics S.A.

Oryzon Genomics S.A.

ORY
Classificação em ações #16859
Oryzon Genomics S.A., a clinical stage biopharmaceutical company, engages in... Oryzon Genomics S.A., a clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS (central nervous system), oncology, and hematology disorders. Its clinical phase compounds include iadademstat (ORY-1001), a selective LSD1 inhibitor that is in Phase II trials for oncology; and vafidemstat (ORY-2001), a CNS-optimized LSD1 inhibitor, which is in Phase II trials for the treatment of CNS and psychiatric diseases. Its product candidates also comprise ORY-3001, an LSD1 inhibitor that is in preclinical development for the treatment of non-oncological diseases; and ORY-4001, a selective HDAC-6 inhibitor for the treatment of neurological disorders, such as Charcot-Marie-Tooth disease (CMT), amyotrophic lateral sclerosis (ALS), and others. It also has collaborations in precision medicine with Columbia University in New York and the Institute of Medical and Molecular Genetics (INGEMM) at La Paz Hospital in Madrid psychometrically characterize patients with mutations in the SetD1A or Shank3 genes; and Cooperative Research and Development Agreement (CRADA) to sponsor several clinical trials. The company was incorporated in 2000 and is based in Cornellà de Llobregat, Spain.
Preço da ação
$3.32
Valor de mercado
$272.01M
Variação (1 dia)
0.21%
Variação (1 ano)
8.43%
País
ES
Negociar Oryzon Genomics S.A. (ORY)

Categoria

Healthcare
Histórico de preços das ações de Oryzon Genomics S.A. (ORY)
Preço de fecho mais alto: $3.32 em 2026-09-01

Preço de fecho mais baixo: $4.05 em 2015-12-01
Histórico de preços das ações da Oryzon Genomics S.A. de 2015 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -3.02%
2025 127.05%
2024 -28.98%
2023 -7.72%
2022 -20.86%
2021 -17.47%
2020 14.60%
2019 14.88%
2018 -16.03%
2017 -30.04%
2016 21.22%
2015 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $548.15 36.70%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 45.33%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $153.87 536.09%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.21 -10.03%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $757.71 8.20%
CH